PortfoliosLab logoPortfoliosLab logo
NZAC vs. PBPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NZAC vs. PBPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR MSCI ACWI Climate Paris Aligned ETF (NZAC) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NZAC achieves a 7.28% return, which is significantly lower than PBPH's 7.71% return.


NZAC

1D
0.40%
1M
0.10%
6M
6.19%
YTD
7.28%
1Y
18.88%
3Y*
16.58%
5Y*
9.32%
10Y*
11.72%
ALL TIME*
10.06%

PBPH

1D
-1.24%
1M
-2.58%
6M
4.02%
YTD
7.71%
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$201.08K$143.38K$203.83K
$2.67M$4.96M$3.73M

NZAC vs. PBPH - Yearly Performance Comparison


Correlation

The correlation between NZAC and PBPH is 0.26, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (All Time)
Calculated using the full available price history since Nov 25, 2025

0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NZAC vs. PBPH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NZAC
NZAC Risk / Return Rank: 5151
Overall Rank
NZAC Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
NZAC Sortino Ratio Rank: 5050
Sortino Ratio Rank
NZAC Omega Ratio Rank: 4949
Omega Ratio Rank
NZAC Calmar Ratio Rank: 4848
Calmar Ratio Rank
NZAC Martin Ratio Rank: 5858
Martin Ratio Rank

PBPH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NZAC vs. PBPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI ACWI Climate Paris Aligned ETF (NZAC) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NZACPBPHDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.22

Calmar ratioReturn relative to maximum drawdown

1.74

Martin ratioReturn relative to average drawdown

6.88

NZAC vs. PBPH - Sharpe Ratio Comparison


Loading charts...

Drawdowns

NZAC vs. PBPH - Drawdown Comparison

The maximum NZAC drawdown since its inception was -33.72%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for NZAC and PBPH.


Loading charts...

Drawdown Indicators


NZACPBPHDifference

Max Drawdown

Largest peak-to-trough decline

-33.72%

-11.10%

-22.62%

Max Drawdown (1Y)

Largest decline over 1 year

-10.10%

Max Drawdown (3Y)

Largest decline over 3 years

-16.19%

Max Drawdown (5Y)

Largest decline over 5 years

-28.31%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-2.23%

-3.03%

+0.80%

Average Drawdown

Average peak-to-trough decline

-5.28%

-4.04%

-1.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.55%

Volatility

NZAC vs. PBPH - Volatility Comparison


Loading charts...

Volatility by Period


NZACPBPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.07%

Volatility (6M)

Calculated over the trailing 6-month period

11.66%

Volatility (1Y)

Calculated over the trailing 1-year period

14.03%

17.84%

-3.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.96%

17.84%

-0.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.07%

17.84%

-0.77%

NZAC vs. PBPH - Expense Ratio Comparison

NZAC has a 0.12% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

NZAC vs. PBPH - Dividend Comparison

NZAC's dividend yield for the trailing twelve months is around 2.07%, more than PBPH's 0.08% yield.


PositionTTM20252024202320222021202020192018201720162015
NZAC
SPDR MSCI ACWI Climate Paris Aligned ETF
2.07%1.90%1.88%1.65%1.81%1.62%1.59%2.17%2.53%2.20%2.00%2.40%
PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
0.08%0.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


NZAC and PBPH have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, NZAC is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.

NZAC is cheaper with a 0.12% expense ratio, compared with 0.13% for PBPH.

NZAC has the higher dividend yield at 2.07%, compared with 0.08% for PBPH.

NZAC is categorized as Global Equities, while PBPH is Health & Biotech Equities. NZAC tracks MSCI ACWI Climate Paris Aligned Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: State Street and Portfolio Building Block. Their fees differ too: 0.12% for NZAC and 0.13% for PBPH.

Portfolio Optimizer

Find the right allocation for NZAC and PBPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer